×
For best experience we recommend to activate Javascript in your browser.
AGXT2 antibody (AA 226-513)
This Rabbit Polyclonal antibody specifically detects AGXT2 in WB, IHC, IP and ICC. It exhibits reactivity toward Mouse.
Quick Overview for AGXT2 antibody (AA 226-513) (ABIN7610770)
Target
See all AGXT2 Antibodies
AGXT2
(Alanine Glyoxylate Aminotransferase 2 (AGXT2))
Reactivity
All reactivities for AGXT2 antibodies
Mouse
Host
All hosts for AGXT2 antibodies
Rabbit
Clonality
All clonalities for AGXT2 antibodies
Polyclonal
Conjugate
All conjugates for AGXT2 antibodies
This AGXT2 antibody is un-conjugated
Application
All applications for AGXT2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-AGXT2 Antibody
(hide)
Binding Specificity
All epitopes for AGXT2 antibodies
AA 226-513
Purpose
Alanine Glyoxylate Aminotransferase 2 (AGXT2) Polyclonal Antibody
Sequence
Met226~Lys513
Characteristics
The Alanine Glyoxylate Aminotransferase 2 (AGXT2) Polyclonal Antibody (Species: Mouse) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for AGXT2
(hide)
Target
AGXT2
(Alanine Glyoxylate Aminotransferase 2 (AGXT2))
Alternative Name
AGXT2
Gene ID
268782
UniProt
Q3UEG6
Pathways
Monocarboxylic Acid Catabolic Process
Recently viewed
(hide)
Chat with us , powered by LiveChat